Nusano
  • Company
    • Leadership
    • Mission & Values
    • West Valley City
    • Contact Us
  • Technology
  • Life Sciences
    • Medical Isotopes
    • Request Quote
    • R&D Collaboration
    • Advisory Board
    • About Nuclear Med
  • Industrial
  • Clean Energy
  • Batteries
  • News
    • Press Releases
    • Video
    • Podcast
  • Careers
    • Current Openings
    • Life in Utah
Select Page
Nusano and GlyTherix Announce Lutetium-177 Supply Agreement

Nusano and GlyTherix Announce Lutetium-177 Supply Agreement

by Scott Larrivee | Dec 9, 2024 | News

VALENCIA, Calif. and SYDNEY, Australia – Dec. 9, 2024 – Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody radiopharmaceuticals for solid...
Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development

Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development

by Scott Larrivee | Oct 17, 2024 | News

Image above: Starget Pharma, stargetpharma.com VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide...

Recent Posts

  • Talk Radioisotopes: Sigal Kalmanson Cusnir, CEO and Co-Founder, Starget Pharma
  • Talk Radioisotopes: Milton Lönnroth, Co-Founder and CEO, Atley Solutions
  • Registration for 2025 World Astatine Community Meeting Now Open
  • Nusano to Participate in Radiopharma Supply Chain Panel at the 21st Annual PEGS Summit Boston
  • Talk Radioisotopes: Dr. Luke Nordquist, Founder & CEO of XCancer

Recent Comments

No comments to show.
Nusano
Supplying the fight against cancer.
  • Follow
  • Follow
  • Follow
Company
about us
Leadership
Contact us
technology

The Nusano Platform
R&D Collaboration

Resources
News
Careers
Suppliers
© 2025 Nusano | Web design
Privacy Policy – Terms of Service